Financials

  • Market Capitalization 2.34 B
  • Employee 357
  • Founded 2009
  • CEO N/A
  • Website www.nurixtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDJ8M78
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.54
Rapporto prezzo/fatturato
17.45

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1835
LQDA
Liquidia Corporation - Common Stock
26.19 USD-5.35%-1.47%-60.79%+15.88%2.34 B USD
1850
ADMA
ADMA Biologics Inc - Common Stock
10.24 USD+0.59%-0.68%+9.75%-29.62%2.29 B USD
1860
CLDX
Celldex Therapeutics, Inc. - Common Stock
28.54 USD-3.02%-9.17%-23.69%+4.77%2.24 B USD
1867
IRON
Disc Medicine, Inc. - Common Stock
58.63 USD-3.06%-8.66%-16.31%-17.99%2.25 B USD

Notizie